Similar articles for PMID: 16120821

Year	Number of Results
1997	1
2001	1
2002	3
2003	2
2004	8
2005	10
2006	12
2007	5
2008	5
2009	8
2010	7
2011	4
2012	6
2013	1
2016	1
2017	1
2018	1
2021	1

1

Additional antiproteinuric effect of ultrahigh dose candesartan: a double-blind, randomized, prospective study.

Schmieder RE, Klingbeil AU, Fleischmann EH, Veelken R, Delles C. Schmieder RE, et al. J Am Soc Nephrol. 2005 Oct;16(10):3038-45. doi: 10.1681/ASN.2005020138. Epub 2005 Aug 24. J Am Soc Nephrol. 2005. PMID: 16120821 Free article. Clinical Trial.

2

Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease.

Song JH, Cha SH, Lee HJ, Lee SW, Park GH, Lee SW, Kim MJ. Song JH, et al. Nephrol Dial Transplant. 2006 Mar;21(3):683-9. doi: 10.1093/ndt/gfi310. Epub 2005 Dec 5. Nephrol Dial Transplant. 2006. PMID: 16330466 Clinical Trial.

3

Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET.

Philipp T, Martinez F, Geiger H, Moulin B, Mourad G, Schmieder R, Lièvre M, Heemann U, Legendre C. Philipp T, et al. Nephrol Dial Transplant. 2010 Mar;25(3):967-76. doi: 10.1093/ndt/gfp581. Epub 2009 Nov 3. Nephrol Dial Transplant. 2010. PMID: 19887503 Clinical Trial.

4

Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors.

Kanno Y, Takenaka T, Nakamura T, Suzuki H. Kanno Y, et al. Clin J Am Soc Nephrol. 2006 Jul;1(4):730-7. doi: 10.2215/CJN.01110905. Epub 2006 May 17. Clin J Am Soc Nephrol. 2006. PMID: 17699280 Free article. Clinical Trial.

5

Antiproteinuric effect of candesartan cilexetil in patients with chronic glomerulonephritis.

Kurokawa K, Abe K, Saruta T, Arakawa M, Kikkawa R, Ueda N, Onoyama K, Tomita K, Ogawa N. Kurokawa K, et al. J Renin Angiotensin Aldosterone Syst. 2002 Sep;3(3):167-75. doi: 10.3317/jraas.2002.037. J Renin Angiotensin Aldosterone Syst. 2002. PMID: 12563567 Free article. Clinical Trial.

6

Angiotensin II receptor blocker and long-acting calcium channel blocker combination therapy decreases urinary albumin excretion while maintaining glomerular filtration rate.

Nakagawa N, Fujino T, Kabara M, Matsuki M, Chinda J, Kikuchi K, Hasebe N; NICE-Combi Study Group. Nakagawa N, et al. Hypertens Res. 2011 Oct;34(10):1121-6. doi: 10.1038/hr.2011.101. Epub 2011 Jul 28. Hypertens Res. 2011. PMID: 21796123 Clinical Trial.

7

Addition of manidipine improves the antiproteinuric effect of candesartan in hypertensive patients with type II diabetes and microalbuminuria.

Fogari R, Corradi L, Zoppi A, Lazzari P, Mugellini A, Preti P, Rinaldi A. Fogari R, et al. Am J Hypertens. 2007 Oct;20(10):1092-6. doi: 10.1016/j.amjhyper.2007.05.012. Am J Hypertens. 2007. PMID: 17903693 Clinical Trial.

8

A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).

Palma Gámiz JL, Pêgo M, Contreras EM, Anglada MP, Martínez JO, Esquerra EA, Sagastagoitia Gorostiza JD; Iberian Multicenter Imidapril Study on Hypertension. Palma Gámiz JL, et al. Clin Ther. 2006 Dec;28(12):2040-51. doi: 10.1016/j.clinthera.2006.12.006. Clin Ther. 2006. PMID: 17296460 Clinical Trial.

9

Efficacy, safety and pharmacokinetics of candesartan cilexetil in hypertensive children from 1 to less than 6 years of age.

Schaefer F, van de Walle J, Zurowska A, Gimpel C, van Hoeck K, Drozdz D, Montini G, Bagdasorova IV, Sorof J, Sugg J, Teng R, Hainer JW; Candesartan in Children with Hypertension Investigators. Schaefer F, et al. J Hypertens. 2010 May;28(5):1083-90. doi: 10.1097/HJH.0b013e328336b86b. J Hypertens. 2010. PMID: 20160654 Clinical Trial.

10

Antiproteinuric effect of candesartan cilexetil in Japanese subjects with type 2 diabetes and nephropathy.

Haneda M, Kikkawa R, Sakai H, Kawamori R; Candesartan in Diabetic Nephropathy Study Group. Haneda M, et al. Diabetes Res Clin Pract. 2004 Oct;66(1):87-95. doi: 10.1016/j.diabres.2004.02.015. Diabetes Res Clin Pract. 2004. PMID: 15364166 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed